Table 1. – Demographic characteristics, comorbid conditions and dual antiplatelet therapy (DAPT) indications of the study population.
| Total n=1500 | STEMI n=395 | NSTE-ACS n=783 | CCS n=322 | p value | ||
|---|---|---|---|---|---|---|
| DAPT indications, n (%) | STEMI | 395 (26.3%) | ||||
| NSTE-ACS | 783 (52.2%) | |||||
| CCS | 322 (21.5%) | |||||
| Age, years | 63 (56 – 71) | 62 (54 – 71) | 64 (56 – 72) | 62 (56 – 69) | 0.013 | |
| Gender (male), n (%) | 1006 (67.1%) | 277 (70.1%) | 527 (67.3%) | 202 (62.7%) | 0.109 | |
| Diabetes mellitus, n (%) | 543 (36.2%) | 136 (34.4%) | 277 (35.4%) | 130 (40.4%) | 0.203 | |
| Hypertension, n (%) | 948 (63.2%) | 226 (57.2%) | 492 (62.8%) | 230 (71.4%) | <0.001 | |
| Family history of CAD, n (%) | 568 (37.9%) | 151 (38.2%) | 273 (34.9%) | 144 (44.7%) | 0.009 | |
| Hyperlipidemia, n (%) | 831 (55.4%) | 208 (52.7%) | 423 (54%) | 200 (62.1%) | 0.022 | |
| Prior CABG,n (%) | 130 (8.7%) | 19 (4.8%) | 85 (10.9%) | 26 (8.1%) | 0.002 | |
| Peripheral arterial disease, n (%) | 114 (7.6%) | 26 (6.6%) | 58 (7.4%) | 30 (9.3%) | 0.383 | |
| Bleeding history, n (%) | 66 (4.4%) | 12 (3%) | 37 (4.7%) | 17 (5.3%) | 0.260 | |
| COPD, n (%) | 165 (11.0%) | 54 (13.7%) | 80 (10.2%) | 31 (9.6%) | 0.136 | |
| History of stroke/TIA, n (%) | 60 (4.0%) | 18 (4.6%) | 35 (4.5%) | 7 (2.2%) | 0.130 | |
| BMI ≥ 30kg/m2, n (%) | 301 (20.1%) | 75 (19%) | 165 (21.1%) | 61 (18.9%) | 0.596 | |
| History of smoking, n (%) | Non-smoker | 619 (41.3%) | 135 (34.2%) | 331 (42.3%) | 153 (47.5%) | <0.001 |
| Former-smoker | 568 (37.9%) | 152 (38.5%) | 309 (39.5%) | 107 (33.2%) | ||
| Active smoker | 313 (20.9%) | 108 (27.3%) | 143 (18.3%) | 62 (19.3%) | ||
| Alcohol, n (%) | 167 (11.1%) | 46 (11.6%) | 97 (12.4%) | 24 (7.4%) | 0.056 | |
| History of COVID-19, n (%) | 608 (40.5%) | 160 (40.5%) | 343 (43.8%) | 105 (32.6%) | 0.003 |
Categorical variables (%) and continuous variables presented frequently are shown as median and interquartile range. DAPT: Dual antiplatelet therapy; STEMI: ST-elevation myocardial infarction; NSTE-ACS: Non-ST-segment elevation acute coronary syndrome; CCS: Chronic coronary syndromes; CAD: coronary artery disease; CABG: coronary artery bypass graft; COPD: Chronic obstructive pulmonary disease; TIA: transient ischemic attack; BMI: body mass index; COVID-19: Coronavirus disease 2019.